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Reactive changes occurring within lymph nodes draining the subcutaneous site of acute infection with
maedi-visna virus (MVV) were studied, and the appearance of infected cells correlated with the immune
response. Cells infected with virus were detected in the node by cocultivation from day 4 postinfection (p.i.),
with maximum numbers being seen between days 7 and 14, but even then infected cells were rare, with a
maximum frequency of 23 50% tissue culture infective doses (TCID50) in 10
6 lymph node cells. At later times,
infected cells were still detected, but their numbers fell to 1 to 2 TCID50 per 10
6 cells. Virus-specific CD81
cytotoxic T-cell precursors (CTLp) were isolated from infected nodes from day 10 p.i. onwards, and T-cell
proliferative responses to MVV were first detected on day 7 and consistently detected after day 18. Histological
analysis showed a vigorous immune response in the node. There was a marked blast reaction in the T-cell-rich
zones, which was greatest at the time when the number of virally infected cells was at its height. At this stage,
large numbers of plasma cells were seen in the medullary cords, indicating that extensive T-cell-dependent
B-cell activation was occurring in the T-cell-rich zones. Germinal centers were prominent shortly after the
onset of the T-zone response and were still present at 40 days p.i. Phenotype studies of isolated lymph node cells
failed to detect major changes in the proportion or phenotype of macrophages, CD11 interdigitating cells, and
CD41 or CD81 T cells despite the fact that CD81 lymphoblasts form a major population leaving the node in
efferent lymph. This suggests that there is a balanced increase in the number of all cell types in response to
the virus within the node and selective migration of CD81 lymphoblasts containing virus-specific CTLp from
the node. Virus-specific immune responses are therefore present within the node when infectious virus isolation
is maximal, but cellular immunity may act to control the level of infection from day 18 onwards.
The usual course of virus infections can be considered to
follow a number of stages: first, infection and replication of
virus; second, viral antigens (or infected cells) induce an im-
mune response, and lastly, immune effector mechanisms clear
the virus (9, 40). Although most virus infections could be said
to follow this strategy, some immune responses are patholog-
ical for the host (e.g., lymphocytic choriomeningitis virus in-
fection in adult mice) (2, 23), and some viruses evade the
immune response and so are not cleared from the host (her-
pesviruses can become latent in the nervous system or lym-
phoid cells) (35). Of even more interest are those viruses, such
as lentiviruses (29), which evade host immune responses and
persist even though sites of true latency have not been found.
In these cases, the virus continues to replicate, and there is a
gradual buildup of pathology. The lentivirus family includes
the human, simian, and feline immunodeficiency viruses (HIV,
SIV, and FIV, respectively) and the small ruminant lentiviruses
maedi-visna virus (MVV) and caprine arthritis encephalitis
virus.
Specific immune responses are induced in lymphoid tissue,
and it is also in lymphoid tissue that continuing lentiviral rep-
lication occurs during disease progression (11, 31). For humans
infected with HIV, little is known about the initial stages of
infection and induction of immunity because of the subclinical
nature of the infection. It is important to understand the viral
and immunological events that occur in vivo in lymphoid tissue
during primary lentiviral infection that result in viral persis-
tence in order to devise realistic vaccination strategies (12). We
are studying the very early interaction of the lentivirus MVV
with the host immune response within sheep lymphoid tissue.
Sheep are amenable to surgical lymphatic cannulation, and
therefore such a detailed analysis is possible. Previously we
have shown that major histocompatibility complex (MHC)
class II-positive CD81 lymphoblasts exit the acutely infected
lymph node via efferent lymph at about the same time that low
frequencies of virus-infected cells are also detected leaving the
node, disseminating the infection (4). It is now appreciated
that the lymph nodes are major sites of HIV replication
throughout the disease (11, 31), and it is therefore likely that
the virus-infected cells seen leaving acutely MVV-infected
nodes are only a small proportion of the infected cells which
remain in the node. We have therefore looked, first, for the
establishment and maintenance of MVV infection within the
lymph node and, second, for abnormalities in the immune
response to MVV during acute infection of the node which
might prevent viral clearance.
MATERIALS AND METHODS
Animals. Finnish Landrace sheep (1 to 5 years of age) were purchased from
the Moredun Research Institute, Edinburgh, Scotland.
Skin cell lines and virus culture. Autologous skin cell lines for each sheep
were derived from skin biopsies as previously described (4). Autologous cell-
grown MVV strain EV1 (36) was cultured as previously described (4) in Dul-
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becco’s modified Eagle’s medium (DME) supplemented with 2 mM L-glutamine,
100 U of benzylpenicillin plus 100 U of streptomycin per ml, and 2% fetal calf
serum (FCS) (2% DME). Virus was stored at 2808C and diluted in 2% DME to
give 2.5 3 104 50% tissue culture infective doses (TCID50)/ml for injection into
sheep on the day of use. Virus was inactivated for 1 h at room temperature under
a short UV wavelength bulb (Philips TUV 30W/G30 T8). No infectious virus was
detectable after this treatment, and the stock was diluted for injection according
to its original virus titer.
Infection of sheep and preparation of lymph nodes. Sheep were infected with
MVV (4 ml of virus-infected autologous cell supernatant, total 105 TCID50) at
four sites within the drainage area of the prefemoral lymph node. The prefemo-
ral lymph nodes were excised, excess fat was removed, and the nodes were
weighed. Nodes were sectioned transversely, and both end pieces were put into
Hanks’ buffered sterile saline (HBSS). More central sections were snap frozen in
liquid nitrogen and stored at 2808C or fixed in neutral buffered formalin over-
night before being embedded in wax blocks and stored at room temperature. The
end node sections were removed from HBSS, chopped into small pieces with
sterile scissors in 1 ml of RPMI 1640 with 20 mM HEPES (N-2-hydroxyeth-
ylpiperazine-N9-2-ethanesulfonic acid; catalog no. 12-604-54; ICN Flow) supple-
mented with 2 mM L-glutamine, 5 3 1025 M 2-mercaptoethanol, 100 U of
benzylpenicillin per ml, 100 U of streptomycin per ml, and 10% FCS (10%
RPMI), and then teased apart with sterile forceps in three changes of 1 ml each
of 10% RPMI. The cells removed from the node were pooled, and the resulting
node lumps were digested for 30 min in 10% RPMI with 10 mg of collagenase XI
(Sigma C7657) and 20 ng of DNase I (Sigma D5025) per ml at room temperature
with continuous agitation. These lumps were again teased apart with forceps in
three changes of 1 ml each of 10% RPMI, and the cell suspensions were pooled
with the previous suspensions. Cells were purified over Lymphoprep (Nycomed)
(800 3 g, 10 min), and interface cells were washed twice in RPMI supplemented
as above but with 2% FCS (2% RPMI) before suspension in the required
medium for use immediately or storage in 10% dimethyl sulfoxide–90% FCS
under liquid nitrogen. Preliminary experiments showed that a 30-min digestion
with collagenase gave single-cell suspensions with maximal levels of immuno-
globulin production in vitro and good proliferative results and that purification of
the cells on Lymphoprep did not remove significant numbers of large cells.
Quantitation of infectious MVV. Infectious virus was detected by cocultivation
of serial dilutions of isolated lymph node cells on heterologous skin fibroblast
monolayers in DME supplemented as above but with 3% FCS as previously
described (4) followed by detection of virus by staining for MVV gag p15.
CTL assays. Cytotoxic T-lymphocyte (CTL) assays were performed as previ-
ously described (5). Briefly, lymphocyte effectors were made to the required
concentration for effector-target cell ratios of 3:1 to 100:1 before incubation with
target cells for 16 h at 378C in 5% CO2. Targets were 104 autologous or heter-
ologous skin cells either mock infected or infected for 72 h with 0.5 TCID50 of
MVV EV1 per cell labelled overnight with 1 mCi of 51Cr (sodium chromate; 229
to 550 mCi/mg of Cr; ICN Biomedicals, Inc.) per 104 cells. Targets were washed
four times and then incubated with effectors in 10% RPMI in a total volume of
150 ml. The radioactivity in 40 ml of supernatant was counted in a Wallac 1450
Microbeta liquid scintillation counter. The results have been expressed as the
percent MVV specific cytotoxicity, calculated as percent specific 51Cr release
from infected targets minus percent specific 51Cr release from mock-infected
targets 6 the sum of their standard deviations. All values were obtained from
triplicate samples, and spontaneous 51Cr release was always less than 30% of
maximum release.
Effectors were uncultured lymph node cells or lymph node cells cultured for 14
days on autologous MVV EV1-infected skin fibroblasts in 10% RPMI with 5 U
of recombinant human interleukin-2 (IL-2) per ml (5).
Proliferation of lymph node cells to MVV antigen. Lymph node cells were
resuspended in 10% RPMI supplemented with 200 mg gentamicin per ml, and
105 cells were plated per well into flat-bottomed microtiter plates. MVV or
mock-infected antigen was added to a final concentration of 1.75, 3.5, or 7.0 mg
of protein per ml in 200 ml, and the cells were cultured for 5 days at 378C in 5%
CO2. Cultures were pulsed with 1 mCi of [3H]thymidine (20 to 30 Ci/mmol;
Amersham International PLC) per well for the final 5 h, and harvested onto glass
fiber filters with a Tomtec Harvester 96 automatic cell harvester, and radioac-
tivity was counted with a Wallac 1450 Microbeta liquid scintillation counter.
Results have been expressed as the stimulation index of MVV antigen-stimulated
cultures compared with mock antigen-stimulated cultures (mean counts per
minute [cpm] for MVV-stimulated wells/mean cpm for mock-stimulated wells)
for each antigen dilution. Results were obtained from quadruplicate wells.
MVV and mock-infected antigens were prepared from the same sheep fibro-
blast cell line. Supernatants of infected cell cultures (and cultures mock infected
at the same time) showing extensive cytopathic effects were clarified by centrif-
ugation at 10,000 3 g at 48C for 30 min, and virus was then pelleted at 10,000 3
g at 48C for 16 to 18 h, resuspended in phosphate-buffered saline (PBS), and
stored at 2808C. The protein concentrations of each sample were determined by
using a Bio-Rad Microprotein assay kit, and the optimum concentrations for use
in a proliferation assay were determined from trial assays with lymph node cells
from persistently infected sheep.
Histology. Sections of the wax-embedded tissues were cut and stained by the
methyl green pyronin method, which allows lymphoblasts and plasma cells to be
readily identified on the basis of their high mRNA content and decondensed
chromatin. The sections were assessed by an independent observer who had no
knowledge of the time of infection of the sheep. Uninfected lymph node sections
were randomly included as controls.
Immunohistology was performed on 8-mm-thick frozen sections by using
monoclonal antibody (MAb) 415 anti-MVV gag p15, kindly donated by D. J.
Houwers, in combination with biotin-conjugated rabbit anti-mouse immunoglob-
ulin (Sigma), streptavidin-horseradish peroxidase conjugate (Sigma), and 3,39-
diaminobenzidine tetrahydrochloride (Sigma) as substrates.
Immunofluorescence analysis of cell phenotype. The phenotype of cells iso-
lated from the lymph nodes was determined by using a panel of MAbs against
sheep surface molecules (Table 1). Analysis was carried out on a Becton Dick-
inson FACScan (Becton Dickinson, Mountain View, Calif.). Ten thousand cells,
with dead cells excluded on the basis of forward scatter (FSC), and 4,000 large
cells defined by a gate based on their higher FSC and side scatter (SSC) prop-
erties (see Fig. 5A) were analyzed per lymph node with Consort 30 version F
(Becton Dickinson). MHC class II DR and DQ and IL-2 receptor expression
were analyzed on strongly positive CD41 and CD81 lymphocytes by two-color
analysis as described previously (4).
RESULTS
A series of prefemoral lymph nodes were obtained at differ-
ent times after local MVV infection (4 days to approximately
18 months p.i.). Each infected node was from a different sheep
(two sheep at each time point removed on different days), and
eight prefemoral nodes were removed from uninfected sheep
as controls. In addition, two sheep were mock infected with
UV-inactivated MVV prior to lymph node removal. Single-cell
suspensions derived from the nodes were used to analyze the
appearance of infected cells and the specific immune response
to MVV, and these were correlated to histological changes
within the nodes.
Time course of virus output. Cell-associated virus could be
detected by cocultivation in all but two infected lymph nodes
FIG. 1. Frequency of infectious MVV cells recovered from MVV-infected
lymph nodes. Infectious virus was detected by cocultivation of stored lymph node
cells on sheep skin fibroblast monolayers for 12 to 14 days, after which the
monolayers were stained by immunofluorescence for MVV gagp15. p, no MVV
detectable by cocultivation. The day p.i. is shown on the x axis, with individual
sheep numbers indicated. ND, not done.
TABLE 1. Specificity of MAbs for cell phenotyping
MAb clone Specificity Reference
OM1 CD11c a chain 17
VPM65 CD14 16
VPM5 CD1 7
SBU-T4 CD4 27
SBU-T8 CD8 27
T197 T19 25
DU2-104 Pan B 26
VPM36 MHC class II DQ 10
VPM54 MHC class II DR 10
ILA-111 IL-2R CD25 28
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(Fig. 1), and all postinfection samples were positive for MVV
DNA by PCR on cellular DNA (data not shown). This indi-
cates that viral replication was occurring in all nodes by 4 days
after infection. The frequency of infected cells, measured by an
infectious center assay, was maximal between days 7 and 14 p.i.
and was reduced by day 18 p.i., but the maximum frequency of
cells with infectious MVV was only 23 TCID50 per 10
6 total
lymph node cells (day 14 p.i.). When lymph node sections were
stained for gag p15 antigen-positive cells, a maximum of only
one to two such cells were seen per field (3100 magnification),
again suggesting a low frequency of productively infected cells.
Specific cellular immune responses to MVV antigen. The
development of the cellular immune response to MVV was
studied by using a cytotoxic assay predominantly measuring
CD81 lymphocytes (5) and a T-cell proliferation assay.
The development of the CTL response was studied by as-
saying both for active CTL not requiring secondary in vitro
stimulation and for precursor CTL (CTLp) activated by a
2-week culture with MVV antigen and IL-2. CTLp were de-
tected as early as day 10 p.i. (one of two sheep) and then
consistently after day 12 p.i. (Fig. 2A). Cytotoxicity was medi-
ated by CD81 lymphocytes, as activity was lost when these cells
were removed by complement lysis (data not shown). This
reactivity was specific for strain EV1 MVV, the strain used to
infect the sheep, CTLp activity was never seen against strain
1514 MVV, an Icelandic isolate which has been passaged many
times in vitro (data not shown). In addition, CTLp activity was
not detected 14 days after UV-inactivated virus challenge. At
no time post-MVV infection were CTL which were active
detected directly from the node (Fig. 2B).
Within efferent lymph samples from acutely infected nodes,
only one of five sheep showed CTL activity without culture (4).
We have since gone back to frozen efferent lymph cell samples
and looked for the presence of CTLp. They were first detected
leaving a prefemoral node between days 9 and 13 p.i. (.13%
autologous compared with ,6.5% heterologous MVV specific
cytotoxicity) and leaving a popliteal node on day 6 (18.6%
autologous compared with 26.4% heterologous MVV specific
cytotoxicity).
MVV-specific proliferation by the lymph node cells was first
detected on day 7 p.i. (both sheep showed positive proliferative
responses) (Fig. 3). This response was then lost until day 12 to
14 p.i. (one sheep at each time point was positive) and was
consistently seen after day 18 p.i. Sheep-to-sheep variation
(both in their immune response genes and in the ability of virus
to replicate) may have affected the time at which proliferation
was seen for each individual. This proliferative assay has been
shown to predominantly measure the CD41 lymphocyte-me-
diated response (33).
Infectious MVV (as detected by cocultivation) was therefore
seen in the lymph node cell fraction before either detectable
proliferative or CTL responses (MVV detected by day 4 p.i.).
MVV-infected cells were also detected when there was a good
proliferative and CTLp response (for example, one sheep at
day 14 p.i. showed MVV-specific stimulation indices of greater
than 40 and MVV specific cytotoxicity of greater than 40% and
had 9 TCID50 in 10
6 cells), although the maximal titers of
infected cells were seen in a node at 14 days p.i., when there
was a poor cytotoxic response and no detectable proliferative
response.
Lymph node size and histological changes. From day 12
onwards, all acutely infected nodes were heavier than any
control node (control group median, 0.83 g; range, 0.74 to 1.30
g) except for one node on day 18 p.i. The largest lymph nodes
were removed on day 12 p.i., with a median weight of 2.85 g.
Histological examination of sections of MVV-infected nodes
showed changes indicative of a vigorous immune response, and
the timing and intensity of some of the major features of this
response are summarized in Table 2. Three components of the
response were readily identified. First, activated lymphocytes
were particularly prominent in the T-cell-rich paracortical area
(T zone) adjacent to the intranodal lymphatics between days 4
and 18 p.i. These were identified by their large nuclei with
open chromatin, the presence of active nucleoli, and abundant
rRNA and mRNA, indicated by strong pyroninophilia in the
nucleoli and cytoplasm of these cells (Fig. 4A). Second, plasma
cells were seen in the medullary cords (Fig. 4B) but only from
days 7 to 18 p.i., which coincides with the timing of the T-zone
FIG. 2. Appearance of CTL in MVV-infected lymph nodes. Lymph node
cells were either cultured for 14 days with live viral antigen and IL-2 (A) or used
directly from the node (B) in 16-h cytotoxic assays. Targets were autologous
(solid bars) or heterologous (open bars) skin cells either mock infected or
infected with 0.5 TCID50 of MVV strain EV1 per cell for 72 h at the end of the
assay. Lymph node cell effectors were used at various effector-target cell ratios of
25:1 (A) and 50:1 (B) or the maximum values indicated: p, 25:1; ¶, 20:1; †, 12:1;
‡, 10:1; or §, 6:1. The day p.i. is shown on the x axis, with individual sheep
numbers indicated. N.D., not done.
FIG. 3. Lymph node cell proliferation to MVV antigen. A total of 105 cells
from lymph node single-cell suspensions were cultured with both MVV- and
mock-infected antigen at antigen dilutions of 1.7 (open bars), 3.5 (hatched bars),
and 7.0 (solid bars) mg of protein per ml for 5 days before being labelled for 5 h
with [3H]thymidine and harvested. Results are expressed as the stimulation index
(MVV antigen cpm)/(mock antigen cpm), with error bars showing the standard
deviation. Samples with two or more points in the dilution series giving stimu-
lation indices of .2 have been taken to show positive stimulation by MVV
antigen (1). The day p.i. is shown on the x axis, with individual sheep numbers
indicated.
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blast reaction. Frequent cells which had a pyroninophilic cyto-
plasm characteristic of plasma cells were seen undergoing ap-
optosis in the medulla, suggesting that these plasma cells were
short-lived. Apoptotic nuclear fragments were also found in
macrophages of the medullary cords when plasma cells were
present (Fig. 4B). Third, vigorous germinal center reactions
occurred from day 10 and were still present at day 40 p.i. By
immunohistology, there was no evidence that MVV antigen
(gag) was trapped on the follicular dendritic cell network
within germinal centers, as is seen with HIV and SIV (data not
shown).
Phenotypic changes on lymph node cells. Lymph nodes con-
tain a variety of mononuclear cell types: macrophages, inter-
digitating cells, and follicular dendritic cells as well as lympho-
cyte populations. Approximately 3% of cells were CD11 large
cells and were considered to represent antigen-presenting in-
terdigitating cells, while 5% of cells were CD11c1 (CR4) and
CD141 (lipopolysaccharide receptor) macrophage-like cells in
control uninfected sheep, as shown in Table 3. At no time point
postinfection did the percentage of these cell subsets alter
significantly from those in uninfected controls.
In efferent lymph draining acutely MVV-infected nodes, one
of the major features of the response to MVV was a rise in the
percentage of large lymphoblasts, in particular, a marked rise
in the percentage of CD81 lymphoblasts exiting the node be-
tween days 6 and 11 p.i., with the timing of this response
varying among the sheep (4). To compare the node data with
that seen in efferent lymph, the percentage of CD4, CD8, and
B cells was analyzed in both small and large lymphocyte boxes
defined by their FSC/SSC profile on FACS analysis (Table 3
and Fig. 5). No significant increase in the percentage of large
cells in the node was detected following MVV infection, and
only at day 12 p.i. did both sheep nodes have a significantly
raised percentage of CD81 lymphoblasts (median, 15.5%)
compared with uninfected nodes (median, 5.4%) (Fig. 5B).
The percentage of CD81 small lymphocytes was slightly but
not significantly raised from that at day 12 p.i. (data not
shown). The rise in CD81 lymphocytes within the node is
therefore much less marked and later than that seen in drain-
ing efferent lymph following MVV infection.
The CD81 lymphoblasts in efferent lymph had a very dis-
tinctive IL-2 receptor-negative (IL-2R2), MHC class II DR
and DQ profile (moderate DR with low DQ expression) sug-
gestive of a homogeneous activation state. No IL-2R was ever
detected on CD81 lymphocytes within the node. The MHC
class II antigen expression of large and small CD81 cells for a
sheep node with a high percentage of these CD81 cells at day
12 p.i. is shown in Fig. 5C and D. The DR and DQ antigen
expression was always very heterogeneous on large CD81 lym-
phocytes, and although it was more homogeneous on CD81
small lymphocytes, the level of expression of both isotypes is
greatly reduced compared with that seen on the large CD81
cells leaving the node via efferent lymph (4).
The percentage of CD41 and gd T-cell receptor-positive (as
measured phenotypically by T19 antigen expression) lympho-
cytes did not show any significant alterations with time p.i. In
contrast, two sheep injected with UV-inactivated MVV
showed a rise in the percentage of small and large CD41 cells
in the node over the first 14 days (52.5 and 34.6%, respectively,
on day 14). The percentage of B cells in infected nodes was not
significantly different from that in uninfected nodes, but the
control nodes showed extremely variable B-cell numbers, mak-
ing significant changes unlikely.
DISCUSSION
The developing immune response to MVV within the lymph
node draining the site of infection is described here and related
to the recovery of infectious virus. This extends our previous
studies on this relationship in draining efferent lymph from
acutely infected nodes (4). Draining efferent lymph contains
cells and factors that disseminate the response systemically, but
it is within the lymph node that the major initial interaction of
virus with the cells of the immune system occurs.
All the nodes from infected sheep had evidence of viral
replication, but the frequency of virus-positive cells assessed by
cocultivation was low (maximum, 23 TCID50 in 10
6 cells). Only
a small proportion of the MVV-susceptible cell lineages (13–
15, 30) within the node were therefore infected, as macro-
phages and dendritic cells made up 1 to 8% of the isolated
lymph node cells. Lentiviruses are known to exist in cells in
vivo in highly restricted replication states (6, 19), and virus
cocultivation assays may detect only a proportion of MVV-
infected cells. Despite their low frequency, the number of
infectious cells clearly peaked between days 7 and 14 p.i. After
this time, the frequency of infectious cells dropped 10-fold,
although MVV-positive cells could always be detected, con-
firming that the infection was never completely cleared from
the initial draining lymph node.
It is difficult to compare the frequency of virus-infected cells
from cocultivation assays with data for other lentiviruses, such
as SIV and FIV, for which most information comes from in situ
hybridization studies. In lymph nodes from SIV- or FIV-in-
fected animals (within 3 months p.i.), many sections are neg-
ative for virus-infected cells by both antigen staining and in situ
hybridization, but may rarely have up to 40 infected cells per
field (3, 32, 34, 38). These frequencies do not seem to be very
different from those seen in the studies of MVV-infected sheep
TABLE 2. Histology of acutely MVV-infected lymph nodes
Sheep no. Day p.i. T-zonereactiona
Plasma cells
in medullary
cordsb
Germinal
center
reactionc
1138W 0 2 2 2
1212T 4 1 1 1
1127W 4 1 1 1
1235T 7 11 11 Early
678R 7 End stage 11 2
1112W 10 2 1/2 11
1119W 10 11 11 11
1215V 12 2 1/2 1/2
1245T 12 11 11 11
1250T 14 2 1/2 1/2
1254T 14 111 111 111
1219V 18 11 11 11 or 2
1131W 18 11 11 111
1238T 23 2 1 1 or 2
573V 23 2 1/2 111
1107W 40 2 2 111
663R 40 2 2 11
1091P 630 2 2 1/2
1078P 534 1 1 1
1071P 599 2 2 2
638R rhsd 7 1 1 11
638R lhsd 14 1 1 1 or 2
aWithin the outer T-cell-rich zone, the lymphoblast response was scored as:2,
quiescent; 1, a few blasts detectable; 11, many blasts detectable; or 111,
intensive blast response.
bMedullary cords contained: 2, no or very occasional; 1, relatively few; 11,
many; or 111, confluent plasma cells.
c The follicles contained: 2, no; 1, small; 11, well developed; or 111,
extensive germinal centers.
d UV-inactivated MVV controls.
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reported here and previously (37), especially as there is no
lymphocyte involvement in MVV infection.
Within efferent lymph draining acutely MVV-infected lymph
nodes, low frequencies of virus-infected cells were also seen by
cocultivation which peaked on days 9 to 14 p.i. and then de-
clined (4). The periods of maximal MVV infection in the node
and efferent lymph are therefore very similar. The frequency of
infectious cells is also very similar to that seen in draining
efferent lymph, which is surprising considering that the major
cellular targets for infection by MVV (macrophages and prob-
ably dendritic cells) are very rare in efferent lymph compared
with the numbers found in lymph nodes. The proportion of
macrophages (or dendritic cells) infected in efferent lymph
must therefore be higher than that within the node, suggesting
that altered migration of these infected cells occurs, allowing
increased dissemination of the virus.
The periods of MVV infection in efferent lymph and lymph
nodes are coincident with a specific immune response. Anti-
body to MVV gag p25 and env can be detected in draining
efferent lymph from as early as day 4 p.i. (4), and this corre-
FIG. 4. Histological appearance of a prefemoral lymph node (sheep 1254T) at 14 days after local infection (methyl green pyronin staining; DNA blue-green with
methyl green, and RNA crimson red with pyronin; magnification, 3500). (A) Section through the T-cell-rich zone. Several large pyroninophilic blast cells are present;
three of these are indicated by arrows. (B) Section through a medullary cord which is full of intensely pyroninophilic plasma cells. The cytoplasm of macrophages in
this area is almost unstained, and the strongly stained apoptotic (tingible) bodies (indicated by arrows) are easily seen against this pale background.
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sponds to the time when plasma cells first appear in the med-
ullary cords of the nodes. The humoral immune response may
therefore contribute to the local containment of MVV in the
lymph nodes of sheep. However, we were unable to detect
MVV-specific antibody-producing cells in vitro by either p25
gag enzyme-linked immunosorbent spot assays (ELISA) or
ELISA and Western (immunoblot) analysis of supernatant
from cultured lymph node cells (data not shown). MVV-spe-
cific T-cell proliferative responses were detected within lymph
node cells weakly on day 7 and consistently from day 18 p.i.,
while these responses were not seen until day 15 to 18 p.i. in
efferent lymph (4). Proliferation to MVV antigen may not have
been seen early with efferent lymph cells, as these showed a
period of unresponsiveness to mitogen, concanavalin A, and
IL-2. There was no evidence within the node for a period of
unresponsiveness to IL-2 or mitogenic stimulation with con-
canavalin A or phytohemagglutin (data not shown), but there
was a period, days 10 to 14, when proliferation to MVV was
lost, and in both the node and its draining lymphatic, this was
the period when the number of infected cells was increasing.
CTLp were also detected during the period when infected cells
were seen (from day 10 p.i.). However, virus-infected cell levels
decreased and were maintained at low levels after the devel-
opment of the specific immune response to MVV, suggesting
that immunity does play a strong role in limiting viral load.
CTLp were detected leaving acutely infected lymph nodes
on day 6 p.i. (popliteal) and days 9 to 13 p.i. (prefemoral). This
corresponded for each node to the characteristic appearance
of CD81 lymphoblasts in the draining lymphatic. It is likely
that part of this CD81 lymphoblast response includes virus-
specific cells, although there may also be a polyclonal expan-
sion of CD81 lymphocytes. This is seen in the response to
influenza virus, when many CD81 cells show active cytokine
transcription, although not all are influenza virus specific (8).
The time of appearance of CTLp within the lymph node and
efferent lymph corresponds well with the appearance of CTLp
to SIV in blood (4 to 6 days p.i.) (39) and also in lymph nodes
(7 days p.i.) (32) after intravenous challenge with SIV. How-
ever, it is much earlier than the detection of CTLp in blood
after subcutaneous infection with MVV, which did not occur
until between 3 weeks and 3 months p.i. (5).
The percentage of CD81 lymphoblasts did not alter signif-
icantly within the node at the time when we previously de-
tected release of CD81 lymphoblasts into efferent lymph, but
there was up to a threefold increase in node weight and the
appearance of blast cells in the T zones of the nodes. This
suggests that there is a balanced increase in all lymphoblast
numbers, and therefore selective migration of CD81 lympho-
blasts at a particular activation state (which we detected as a
specific IL-2R and MHC class II profile) into efferent lymph is
occurring. In the mouse model of influenza virus infection,
there was also no increase seen in the percentage of CD81
lymphocytes within the mediastinal lymph node (1). A rise in
the percentage CD81 cells was only seen in the lung, where
active virus replication was occurring. These data support our
conclusion that after viral infections, specific CD81 lympho-
cytes rapidly leave the node.
It is interesting to try to relate the in vitro immune response
and virus data to the histological events occurring within the
node. Experiments in rodents show that blast reactions in the
T zone are dependent on the continued availability of antigen
to B cells and interdigitating cells (24). Free antigen is rapidly
eliminated in the presence of antibody, and the administration
of antigen to an animal with a high specific antibody titer only
induces a T-zone response for 3 to 4 days (24). As anti-MVV
antibody is present from day 4 onwards, it seems likely that the
extensive blast reaction in the T zone between days 4 and 18 is
driven by the production of MVV by infected macrophages or
FIG. 5. Kinetics of appearance and MHC class II expression of large CD81
lymphocytes isolated from MVV-infected lymph nodes. (A) FSC/SSC profile of
cells recovered from a day 12 infected lymph node, showing the box used to
analyze large lymphocytes. (B) Levels of CD81 large lymphocytes determined by
immunostaining and FACS analysis. Median and range are given for each time
point. Seven uninfected nodes were analyzed at time zero, and two infected
nodes were analyzed at other time points. Three persistently infected (PI) nodes
were from sheep infected for approximately 18 months (see Table 2). (C and D)
MHC class II DR and DQ expression on small (FSC, 62 to 103; SSC, 6 to 42) (C)
and large (FSC, 109 to 255; SSC, 0 to 80) (D) high-intensity (fluorescence
channel 2 [FL2], 160 to 255) CD81 lymphocytes analyzed by double staining of
cells from a day 12 infected lymph node with anti-CD8 and either normal mouse
serum (z z z z), anti-DR (——), or anti-DQ (zzzz).
TABLE 3. Phenotype of cells recovered from control uninfected and persistently MVV-infected lymph nodes
Sheepa
% of total cells % of small lymphocytes % of lymphoblasts
CD41 CD81 CD11 CD11c1 Large cells CD41 CD81 Pan-B cell1 CD41 CD81 Pan-B cell1
Control
Median 37.1 9.4 3.2 4.8 14.8 39.6 14.0 34.4 22.0 5.4 36.5
Range 15.3–40.2 2.7–14.5 1.2–5.5 1.5–8.0 4.0–22.0 18.0–47.0 4.0–18.0 20.0–65.0 8.0–36.0 2.0–8.0 27.0–55.0
Infected
Median 43.0 15.5 4.4 7.3 13.0 50.9 17.8 19.4 23.3 11.4 25.6
Range 38.9–54.0 11.5–20.0 2.6–6.0 5.0–8.0 11.0–16.0 42.0–59.0 15.0–23.0 11.7–29.5 10.0–32.0 4.0–12.0 24.1–61.3
a Prefemoral lymph nodes from seven uninfected control sheep and persistently infected sheep 1091P, 1078P, and 1071P (see Table 2) were analyzed.
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interdigitating cells throughout this period and only subsides
when the number of virus-infected cells diminishes (after day
14 p.i.). Although some of the viral antigen that has bound
antibody will be taken up and destroyed by macrophages, some
will become localized on follicular dendritic cells. While anti-
gen on these cells is involved in the activation of T and B cells
in follicles, it does not induce or maintain lymphocyte prolif-
eration in T zones (24). In HIV infection, during which large
amounts of antigen persist in the follicles, there is usually
relatively little lymphocyte activation in T zones. The presence
of plasma cells in the medullary cords of lymph nodes or the
equivalent area of the spleen, the red pulp, is directly linked to
recent T-cell-dependent B-cell activation in the adjacent T
zones. Plasma cells were seen in the medulla of infected nodes
between days 4 and 23 p.i. This is consistent with their being
the direct progeny of B blasts in the T zone. The short life span
of medullary cord plasma cells in rodents seems also to apply
to sheep, for medullary cord plasma cells were only seen in the
nodes showing a T-zone blast reaction or within 5 days after it
ended, and apoptotic plasma cells were seen during this time.
Germinal centers are also characteristic of T-cell-dependent
antibody responses (21) and are sites of massive clonal expan-
sion of B cells (22). Germinal centers are formed from a small
proportion of the B blasts activated in the T zone. From the
time of arrival of blasts in the follicle to the end of the germinal
center reaction is about 3 weeks (24). The persistence of ger-
minal centers for 3 weeks after the end of the T-zone reaction
is consistent with the reported duration of germinal center
responses in rodents. It therefore appears that these acutely
infected lymph nodes show many of the typical histological
responses of primary antigenic stimulation.
The data presented here and previously (4) show that within
the first 14 days after infection with the lentivirus MVV, there
was increasing virus replication within lymphoid tissue. During
this time, a specific immune response was induced which
showed many of the histological features seen in primary pro-
tein antigen responses and included a CD81 lymphoblast re-
sponse containing MVV-specific CTLp. After this immune re-
sponse was detected, the number of infected cells decreased
and, histologically, antigen presentation to T cells appeared to
cease. Despite this normal histological response, the MVV-
specific proliferative response was not detectable between days
10 and 14, and this might allow sufficient virus replication and
dissemination for persistence to be established. The continuing
low frequency of MVV-positive cells detected in the nodes
after day 14 p.i. is evidence for this lentiviral persistence. Once
a reservoir of infected cells is established, restricted virus rep-
lication in vivo may then become an important immune eva-
sion mechanism (6, 18). Parallel studies on these nodes to
examine the extent of restricted virus replication within lymph
node cells are in progress.
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